Background and Purpose We investigated the trends in the prescribing of antiseizure
medication (ASM) over a 9-year period, and provide real-world data regarding ASM …

Long-term (up to 8 years of exposure) safety and efficacy of the antiepileptic drug
lacosamide was evaluated in this open-label extension trial (SP615 [ClinicalTrials. gov …

Purpose Perampanel (PER) and lacosamide (LCM) are the new third-generation anti-
seizure medications (ASMs) that were approved for the monotherapy of focal epilepsy in …

Aim The goal of antiepileptic treatment is to achieve seizure freedom or seizure control. The
aim of this paper is to review the evidence for the use of lacosamide for adjunctive treatment …

Objectives: The aim of this study was to investigate the antiepileptic drug (AED) treatment of
adults suffering from focal epilepsies (FE) in Germany. Of special interest was the number …

Lacosamide (Vimpat®) is a functionalized amino acid available orally (as a solution or
tablets) and as an intravenous infusion for use as monotherapy (only in the USA) or …

Objective To assess effectiveness and tolerability of first‐line and conversion to lacosamide
monotherapy for focal seizures. Materials and Methods Retrospective, non‐interventional …

Purpose Lacosamide (LCM) was recently introduced in the Middle East. The aim of this
study was to evaluate the safety, tolerability, and efficacy of LCM in patients with focal onset …

Objectives Epilepsy management in elderly patients is often complex because of several
concomitant comorbidities that may limit the use of some antiepileptic drugs (AEDs) …

Background Overall, up to one-third of epilepsy patients have drug-resistant epilepsy.
However, there was previously no meta-analysis to support the guidelines for broad …